androgenic alopecia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The typical clinical manifestations were consistent with the diagnosis of AGA, and the degree of hair loss was consistent with the BASP classification of androgenic hair loss in male patients aged 20-60 years; 2. Generally good patients (no previous heart, systemic, scalp disease), the first 3 months of the study did not use any drugs that may affect the growth of hair (antihypertensive drugs, hormones, cytotoxic drugs, drugs with antiandrogenic effects, etc.); 3. Agree to participate in observation and follow-up, willing to accept the follow-up, can closely cooperate with the whole process of patients.
Exclusion criteria
Exclusion criteria: (1) Oral administration of finasteride within 18 months before the start of the test; (2) Use topical or systemic drugs that affect hair growth within 12 months; (3) History of hair transplantation; (4) Systemic or scalp diseases that may affect hair growth.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The same photographic method, according to P. Suchonwanit et AL's 7-point rating scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of Alopecia Tool, SALT;Evaluation of hair regeneration rate;The hair thickness and hair density of Aga patients before and after treatment were measured by Dermatoscope, and the improvement was judged by comparing the median hair density and width (width) .;Evaluation of subjective satisfaction of patients;The quality of life (Qol) of patients was investigated by using the international dermatological quality of life questionnaire; | — |
Countries
China
Contacts
Shanghai Tongji hospital